NCT02262676已完成不适用
Observational and Cross-sectional Study to Assess the Sociodemographic and Clinical Characteristics of Patients Treated With RIVAROXABAN in the Context of Routine Clinical Practice of Spanish Haematologists, Cardiologists and Internists (HEROIC Study)
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Bayer
- 入组人数
- 2,251
- 主要终点
- Medical History
研究概览
简要总结
Depict demographic and clinical features of patients with atrial fibrillation treated with rivaroxaban to prevent stroke and pulmonary embolism in routine clinical practice
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients ≥ 18 years
- •Patients with atrial fibrillation
- •Patients in treatment with rivaroxaban for stroke prevention in atrial fibrillation at least 3 months previous to inclusion period in study
排除标准
- •Patients in treatment after start of study
- •Patients treated with other anticoagulant treatment
研究组 & 干预措施
Rivaroxaban
Patients with Atrial fibrillation treated with Rivaroxaban
干预措施: Rivaroxaban (Xarelto, BAY59-7939) (Drug)
结局指标
主要结局
Medical History
时间窗: At recruitment visit
Demographic Data
时间窗: At recruitment visit
次要结局
- Assess the quality of life in patients(At recruitment visit)
- Assess regional differences among the different Spanish autonomous communities on the management of patients with rivaroxaban treatment during the routine clinical practice(At recruitment visit)
- Adherence to rivaroxaban treatment(At recruitment visit)
- Assess the satisfaction of rivaroxaban treatment(At recruitment visit)
研究者
相似试验
已完成
不适用
Rivaroxaban Evaluation in Real Life SettingsStrokeAtrial FibrillationNCT02444221Thrombosis Research Institute5,278
已完成
不适用
Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden)Atrial FibrillationAcute Coronary SyndromeVenous ThrombosisPulmonary EmbolismNCT02468102Bayer99,999
已完成
不适用
Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Germany)Atrial FibrillationAcute Coronary SyndromeVenous ThrombosisPulmonary EmbolismNCT01947959Bayer665,533
已完成
不适用
Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)Venous ThrombosisAcute Coronary SyndromePulmonary EmbolismAtrial FibrillationNCT01947998Bayer50,299
已完成
不适用
Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands)Atrial FibrillationAcute Coronary SyndromePulmonary EmbolismVenous ThrombosisNCT01947985Bayer208,958